Etiology-Specific Genomic Alterations

Numerous genetic and epigenetic events reveal tumor progression and define the characteristics of tumors. Advances in high-throughput technologies, similar to gene expression profiling, next generation sequencing, proteomics, and metabolomics, have empowered detailed molecular characterization of different tumors. The coordination and investigations of the high-throughput information have unwound numerous novel molecular variations and network alterations in tumors. These molecular changes incorporate different malignant growth driving transformations, gene fusions, amplification, deletion, and post-translational modifications, among others. A large number of these genomic events are being utilized in cancer diagnosis, though others are remedially focused with small-molecule inhibitors. Numerous genes/catalysts that play a role in DNA and histone modifications are additionally modified in different cancers, changing the epigenomic landscape amid malignant growth initiation and progression. Aside from protein-coding genes, studies are revealing the basic administrative roles played by noncoding RNAs and noncoding regions of the genome during malignancy progression. A considerable lot of these genomic and epigenetic events tandem to drive tumor improvement and metastasis. Simultaneous advances in genome-regulating innovations, similar to gene silencing and genome editing, are providing capacity to comprehend in detail the procedure of malignancy initiation, movement, and motioning and additionally opening up roads for therapeutic targeting.

    Related Conference of Etiology-Specific Genomic Alterations

    Etiology-Specific Genomic Alterations Conference Speakers